Physiological activity of pulmonary surfactant with low protein content: Effect of enrichment with synthetic phospholipids

Per Berggren, Tore Curstedt, Gertie Grossman, Roland Nilsson, Bengt Robertson

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

A natural surfactant with low protein content (1% was prepared by a sequence of cold centrifugation, heating to 90 C, sucrose-gradient centrifugation, and extraction with chloroform-methanol. Some of the material was enriched with dipalmitoylphos-phatidylcholine (DPPC) and unsaturated phosphatidylglycerol (PG) to relative concentrations of 56% and 10% respectively. The in vitro physical properties of these preparations were evaluated with pulsating bubble and Wilhelmy balance and their in vivo activity with experiments on artificially ventilated premature newborn rabbits, delivered on day 27 of gestation. The animals were kept in body plethysmographs at 37 C and ventilated artificially with a standardized sequence of insufflation pressures: 25, 20, and 15 cm H2Q. The lungs were fixed by vascular perfusion and the alveolar expansion evaluated morphometrically in histologic sections. Enrichment of surfactant with DPPC and PG resulted in lower minimal surface tension during surface compression but did not further improve lung compliance or the alveolar expansion pattern. Treatment with nonenriched surfactant at a phospholipid concentration of 100 mg/ml (individual dose = 200 mg/kg) caused a markedly increased lung compliance at all insufflation pressure levels fp us. controls <.01). Our data indicate that pulmonary surfactant remains physiologically active after removal of most of its protein components and that enrichment with DPPC and PG reduces the in vitro minimal surface tension without adding to the in vivo efficacy.

Original languageEnglish
Pages (from-to)29-51
Number of pages23
JournalExperimental Lung Research
Volume8
Issue number1
DOIs
StatePublished - Jan 1 1985
Externally publishedYes

Fingerprint

Pulmonary Surfactants
Phosphatidylglycerols
Surface-Active Agents
Lung Compliance
Phospholipids
Insufflation
Surface Tension
Centrifugation
Surface tension
Pressure
Proteins
Chloroform
Heating
Blood Vessels
Methanol
Sucrose
Animals
Perfusion
Physical properties
Rabbits

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Physiological activity of pulmonary surfactant with low protein content : Effect of enrichment with synthetic phospholipids. / Berggren, Per; Curstedt, Tore; Grossman, Gertie; Nilsson, Roland; Robertson, Bengt.

In: Experimental Lung Research, Vol. 8, No. 1, 01.01.1985, p. 29-51.

Research output: Contribution to journalArticle

Berggren, Per ; Curstedt, Tore ; Grossman, Gertie ; Nilsson, Roland ; Robertson, Bengt. / Physiological activity of pulmonary surfactant with low protein content : Effect of enrichment with synthetic phospholipids. In: Experimental Lung Research. 1985 ; Vol. 8, No. 1. pp. 29-51.
@article{9097f552eca94078a9e1b8ddd7c51d0f,
title = "Physiological activity of pulmonary surfactant with low protein content: Effect of enrichment with synthetic phospholipids",
abstract = "A natural surfactant with low protein content (1{\%} was prepared by a sequence of cold centrifugation, heating to 90 C, sucrose-gradient centrifugation, and extraction with chloroform-methanol. Some of the material was enriched with dipalmitoylphos-phatidylcholine (DPPC) and unsaturated phosphatidylglycerol (PG) to relative concentrations of 56{\%} and 10{\%} respectively. The in vitro physical properties of these preparations were evaluated with pulsating bubble and Wilhelmy balance and their in vivo activity with experiments on artificially ventilated premature newborn rabbits, delivered on day 27 of gestation. The animals were kept in body plethysmographs at 37 C and ventilated artificially with a standardized sequence of insufflation pressures: 25, 20, and 15 cm H2Q. The lungs were fixed by vascular perfusion and the alveolar expansion evaluated morphometrically in histologic sections. Enrichment of surfactant with DPPC and PG resulted in lower minimal surface tension during surface compression but did not further improve lung compliance or the alveolar expansion pattern. Treatment with nonenriched surfactant at a phospholipid concentration of 100 mg/ml (individual dose = 200 mg/kg) caused a markedly increased lung compliance at all insufflation pressure levels fp us. controls <.01). Our data indicate that pulmonary surfactant remains physiologically active after removal of most of its protein components and that enrichment with DPPC and PG reduces the in vitro minimal surface tension without adding to the in vivo efficacy.",
author = "Per Berggren and Tore Curstedt and Gertie Grossman and Roland Nilsson and Bengt Robertson",
year = "1985",
month = "1",
day = "1",
doi = "10.3109/01902148509069678",
language = "English",
volume = "8",
pages = "29--51",
journal = "Experimental Lung Research",
issn = "0190-2148",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Physiological activity of pulmonary surfactant with low protein content

T2 - Effect of enrichment with synthetic phospholipids

AU - Berggren, Per

AU - Curstedt, Tore

AU - Grossman, Gertie

AU - Nilsson, Roland

AU - Robertson, Bengt

PY - 1985/1/1

Y1 - 1985/1/1

N2 - A natural surfactant with low protein content (1% was prepared by a sequence of cold centrifugation, heating to 90 C, sucrose-gradient centrifugation, and extraction with chloroform-methanol. Some of the material was enriched with dipalmitoylphos-phatidylcholine (DPPC) and unsaturated phosphatidylglycerol (PG) to relative concentrations of 56% and 10% respectively. The in vitro physical properties of these preparations were evaluated with pulsating bubble and Wilhelmy balance and their in vivo activity with experiments on artificially ventilated premature newborn rabbits, delivered on day 27 of gestation. The animals were kept in body plethysmographs at 37 C and ventilated artificially with a standardized sequence of insufflation pressures: 25, 20, and 15 cm H2Q. The lungs were fixed by vascular perfusion and the alveolar expansion evaluated morphometrically in histologic sections. Enrichment of surfactant with DPPC and PG resulted in lower minimal surface tension during surface compression but did not further improve lung compliance or the alveolar expansion pattern. Treatment with nonenriched surfactant at a phospholipid concentration of 100 mg/ml (individual dose = 200 mg/kg) caused a markedly increased lung compliance at all insufflation pressure levels fp us. controls <.01). Our data indicate that pulmonary surfactant remains physiologically active after removal of most of its protein components and that enrichment with DPPC and PG reduces the in vitro minimal surface tension without adding to the in vivo efficacy.

AB - A natural surfactant with low protein content (1% was prepared by a sequence of cold centrifugation, heating to 90 C, sucrose-gradient centrifugation, and extraction with chloroform-methanol. Some of the material was enriched with dipalmitoylphos-phatidylcholine (DPPC) and unsaturated phosphatidylglycerol (PG) to relative concentrations of 56% and 10% respectively. The in vitro physical properties of these preparations were evaluated with pulsating bubble and Wilhelmy balance and their in vivo activity with experiments on artificially ventilated premature newborn rabbits, delivered on day 27 of gestation. The animals were kept in body plethysmographs at 37 C and ventilated artificially with a standardized sequence of insufflation pressures: 25, 20, and 15 cm H2Q. The lungs were fixed by vascular perfusion and the alveolar expansion evaluated morphometrically in histologic sections. Enrichment of surfactant with DPPC and PG resulted in lower minimal surface tension during surface compression but did not further improve lung compliance or the alveolar expansion pattern. Treatment with nonenriched surfactant at a phospholipid concentration of 100 mg/ml (individual dose = 200 mg/kg) caused a markedly increased lung compliance at all insufflation pressure levels fp us. controls <.01). Our data indicate that pulmonary surfactant remains physiologically active after removal of most of its protein components and that enrichment with DPPC and PG reduces the in vitro minimal surface tension without adding to the in vivo efficacy.

UR - http://www.scopus.com/inward/record.url?scp=0021881769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021881769&partnerID=8YFLogxK

U2 - 10.3109/01902148509069678

DO - 10.3109/01902148509069678

M3 - Article

C2 - 3846531

AN - SCOPUS:0021881769

VL - 8

SP - 29

EP - 51

JO - Experimental Lung Research

JF - Experimental Lung Research

SN - 0190-2148

IS - 1

ER -